BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23253476)

  • 1. TRP channels: diagnostic markers and therapeutic targets for breast cancer?
    Ouadid-Ahidouch H; Dhennin-Duthille I; Gautier M; Sevestre H; Ahidouch A
    Trends Mol Med; 2013 Feb; 19(2):117-24. PubMed ID: 23253476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [TRP calcium channel and breast cancer: expression, role and correlation with clinical parameters].
    Ouadid-Ahidouch H; Dhennin-Duthille I; Gautier M; Sevestre H; Ahidouch A
    Bull Cancer; 2012 Jun; 99(6):655-64. PubMed ID: 22640890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters.
    Dhennin-Duthille I; Gautier M; Faouzi M; Guilbert A; Brevet M; Vaudry D; Ahidouch A; Sevestre H; Ouadid-Ahidouch H
    Cell Physiol Biochem; 2011; 28(5):813-22. PubMed ID: 22178934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors.
    Montanari M; Boninsegna A; Faraglia B; Coco C; Giordano A; Cittadini A; Sgambato A
    J Cell Physiol; 2005 Jan; 202(1):215-22. PubMed ID: 15389519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors.
    Li H; Cherukuri P; Li N; Cowling V; Spinella M; Cole M; Godwin AK; Wells W; DiRenzo J
    Cancer Res; 2007 Jan; 67(2):501-10. PubMed ID: 17234757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between progesterone and prolactin in mammary development and implications for breast cancer.
    Lee HJ; Ormandy CJ
    Mol Cell Endocrinol; 2012 Jun; 357(1-2):101-7. PubMed ID: 21945475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine.
    Nilius B; Szallasi A
    Pharmacol Rev; 2014 Jul; 66(3):676-814. PubMed ID: 24951385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM22 as a prognostic and therapeutic drug target in the treatment of endocrine-resistant breast cancer.
    Bolger JC; Young LS
    Vitam Horm; 2013; 93():307-21. PubMed ID: 23810013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
    Sivko GS; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRP channels and cancer: new targets for diagnosis and chemotherapy.
    Santoni G; Farfariello V
    Endocr Metab Immune Disord Drug Targets; 2011 Mar; 11(1):54-67. PubMed ID: 21348820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRP channel and cardiovascular disease.
    Watanabe H; Murakami M; Ohba T; Takahashi Y; Ito H
    Pharmacol Ther; 2008 Jun; 118(3):337-51. PubMed ID: 18508125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential expression profiles of microRNAs between breast cancer cells and mammary epithelial cells].
    Zhang H; Su SB; Zhou QM; Lu YY
    Ai Zheng; 2009 May; 28(5):493-9. PubMed ID: 19624877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of PSF1 promotes the growth of breast cancer cells.
    Nakahara I; Miyamoto M; Shibata T; Akashi-Tanaka S; Kinoshita T; Mogushi K; Oda K; Ueno M; Takakura N; Mizushima H; Tanaka H; Ohta T
    Genes Cells; 2010 Oct; 15(10):1015-24. PubMed ID: 20825491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinase 6 inhibits proliferation of human mammary epithelial cells.
    Lucas JJ; Domenico J; Gelfand EW
    Mol Cancer Res; 2004 Feb; 2(2):105-14. PubMed ID: 14985467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells.
    Chen J; Miller EM; Gallo KA
    Oncogene; 2010 Aug; 29(31):4399-411. PubMed ID: 20514022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
    Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
    Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
    Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
    Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells.
    Treeck O; Lattrich C; Juhasz-Boess I; Buchholz S; Pfeiler G; Ortmann O
    Br J Cancer; 2008 Oct; 99(8):1246-50. PubMed ID: 18827813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for Runx2 in normal mammary gland and breast cancer bone metastasis.
    Shore P
    J Cell Biochem; 2005 Oct; 96(3):484-9. PubMed ID: 16052475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensing with TRP channels.
    Voets T; Talavera K; Owsianik G; Nilius B
    Nat Chem Biol; 2005 Jul; 1(2):85-92. PubMed ID: 16408004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.